EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Evidence on medicines use and safety during pregnancy: pharmacovigilance or pharmacodrowsinesss ?

Alain Braillon

European Journal of Clinical Pharmacology · 2026-07 · 82 (7)

DOI: 10.1007/s00228-026-04122-7 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 20.06.2026. Verfasst von Alain Braillon. Beteiligte Einrichtung: Independent researcher, Amiens, 80000, France. braillon.alain@gmail.com. Die Arbeit nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

PharmacovigilancePhase IV studyRisk-minimisation measures

Autor:innen und Institutionen

  • Independent researcher, Amiens, 80000, France. braillon.alain@gmail.com.

Zitieren

APA

Braillon, A. (2026). Evidence on medicines use and safety during pregnancy: pharmacovigilance or pharmacodrowsinesss ?. European Journal of Clinical Pharmacology, 82(7). https://doi.org/10.1007/s00228-026-04122-7

Vancouver

Braillon A. Evidence on medicines use and safety during pregnancy: pharmacovigilance or pharmacodrowsinesss ?. European Journal of Clinical Pharmacology. 2026;82(7). doi:10.1007/s00228-026-04122-7

BibTeX
@article{Braillon2026,
  author = {Braillon, Alain},
  title = {Evidence on medicines use and safety during pregnancy: pharmacovigilance or pharmacodrowsinesss ?},
  journal = {European Journal of Clinical Pharmacology},
  year = {2026},
  volume = {82},
  number = {7},
  doi = {10.1007/s00228-026-04122-7}
}
Kostenlos starten →